<DOC>
	<DOCNO>NCT00653861</DOCNO>
	<brief_summary>Safety effectiveness JUVÉDERM™ Injectable Gel Lidocaine compare JUVÉDERM™ without Lidocaine procedural pain treatment nasolabial fold .</brief_summary>
	<brief_title>Safety Effectiveness JUVÉDERM™ Injectable Gel With Lidocaine</brief_title>
	<detailed_description>Controlled , randomize , split-face study subject receive JUVÉDERM™ Injectable Gel Lidocaine ( Ultra Ultra Plus ) one nasolabial fold JUVÉDERM™ Injectable Gel without Lidocaine ( Ultra Ultra Plus ) nasolabial fold . The investigator determine whether subject receives JUVÉDERM™ Ultra Ultra Plus per level correction desire ; lidocaine assignment randomize .</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>Be male female , 18 year age old Desire correction moderate severe nasolabial fold ( NLFs ) Have approximately symmetrical NLFs , i.e. , NLFs pretreatment NLF severity score Have undergo cosmetic facial procedure low 2/3 face within 1 month prior entry study plan undergo procedure study . Begin use new overthecounter prescription , oral topical , antiwrinkle product NLF area within 1 month prior enrollment plan begin use product study . Have undergone previous hyaluronic acid ( HA ) base dermal filler treatment total volume HA inject within 12 month prior study entry within 5 mL recommend annual maximum volume HA dermal filler . Has ever receive semipermanent filler permanent facial implant anywhere face neck , plan implant product study . Have history anaphylaxis , multiple severe allergy , atopy , allergy lidocaine ( amidebased anesthetic ) , hyaluronic acid product , Streptococcal protein , plan undergo desensitization therapy term study . Have active inflammation , infection , cancerous precancerous lesion , unhealed wound NLF area</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Aesthetic correction</keyword>
</DOC>